BioMarin downsizes Roctavian efforts but keeps hemophilia gene therapy for 3 markets 06.08.2024 17:04 Fiercepharma.com BioMarin downsizes Roctavian efforts but keeps hemophilia gene therapy for 3 markets aliu Tue, 08/06/2024 - 10:04
